Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Alimentary Pharmacology & Therapeutics
|
June 25, 2014
Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases
B Pariente, D Laharie
Alimentary Pharmacology & Therapeutics
|
May 4, 2016
Letter: which patient profile for tacrolimus in ulcerative colitis?
D Laharie, F Poullenot
Gastroenterologie Clinique Et Biologique
|
November 18, 2008
[Management of a severe acute colitis]
X Treton, D Laharie
Alimentary Pharmacology & Therapeutics
|
February 9, 2018
Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease
D Laharie, P Riviere
Gut
|
May 14, 1999
Anticipating the onset of inflammatory bowel disease
J F Colombel, D Laharie, B Grandbastien
Inflammatory Bowel Diseases
|
July 12, 2011
Does anti-TNF therapy influence the performance of mycobacterium tuberculosis antigen-specific interferon-gamma assays? A French multicenter experience
E Del Tedesco, X Roblin, D Laharie, et al.
Alimentary Pharmacology & Therapeutics
|
June 19, 2013
Letter: mucosal healing in ulcerative colitis--higher relevance than in Crohn's disease? Authors' reply
D Laharie, J Filippi, X Roblin, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1997
[Uncommon etiology of acute pancreatitis: periarteritis nodosa]
D Laharie, D Neau, O Halle, et al.
Journal of Crohn'S & Colitis
|
September 10, 2015
Association Between Infliximab Trough Levels and the Occurrence of Paradoxical Manifestations in Patients with Inflammatory Bowel Disease: a Case-Control Study
C Coutzac, J Chapuis, F Poullenot, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
September 22, 2020
Assessment of sexual dysfunction in patients with perianal Crohn's disease
R Boudiaf, D Bouchard, P Rivière, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Alimentary Pharmacology & Therapeutics
|
June 25, 2014
Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases
B Pariente, D Laharie
Alimentary Pharmacology & Therapeutics
|
May 4, 2016
Letter: which patient profile for tacrolimus in ulcerative colitis?
D Laharie, F Poullenot
Gastroenterologie Clinique Et Biologique
|
November 18, 2008
[Management of a severe acute colitis]
X Treton, D Laharie
Alimentary Pharmacology & Therapeutics
|
February 9, 2018
Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease
D Laharie, P Riviere
Gut
|
May 14, 1999
Anticipating the onset of inflammatory bowel disease
J F Colombel, D Laharie, B Grandbastien
Inflammatory Bowel Diseases
|
July 12, 2011
Does anti-TNF therapy influence the performance of mycobacterium tuberculosis antigen-specific interferon-gamma assays? A French multicenter experience
E Del Tedesco, X Roblin, D Laharie, et al.
Alimentary Pharmacology & Therapeutics
|
June 19, 2013
Letter: mucosal healing in ulcerative colitis--higher relevance than in Crohn's disease? Authors' reply
D Laharie, J Filippi, X Roblin, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1997
[Uncommon etiology of acute pancreatitis: periarteritis nodosa]
D Laharie, D Neau, O Halle, et al.
Journal of Crohn'S & Colitis
|
September 10, 2015
Association Between Infliximab Trough Levels and the Occurrence of Paradoxical Manifestations in Patients with Inflammatory Bowel Disease: a Case-Control Study
C Coutzac, J Chapuis, F Poullenot, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
September 22, 2020
Assessment of sexual dysfunction in patients with perianal Crohn's disease
R Boudiaf, D Bouchard, P Rivière, et al.
Page
of 5